In focus
Latest feed
Nektar Therapeutics Charts a Course Forward: Q2 2026 Sees Strategic Investment Amidst Financial Shifts
Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals
Global Turmoil Hits Home: HPCL Faces Staggering Loss Amid West Asia Crisis
Bharat Coking Coal Ltd Stumbles in Q1 2026 – Losses Deepen as Revenue Slips
